세계의 종양 정보 시스템 시장 : 솔루션, 서비스, 용도, 최종 사용자별 예측(2025-2030년)

The Oncology Information Systems Market was valued at USD 8.85 billion in 2023, expected to reach USD 9.55 billion in 2024, and is projected to grow at a CAGR of 8.50%, to USD 15.67 billion by 2030.

Oncology Information Systems (OIS) are integral digital infrastructures designed to manage and streamline the complex data and workflows associated with cancer care, including patient records, imaging, treatment plans, and outcomes. These systems are essential for enhancing the efficiency and accuracy of oncology departments, supporting clinicians in delivering personalized treatment, and improving patient outcomes. The primary necessity of OIS lies in its ability to consolidate vast amounts of varied data into a singular, accessible platform, thus facilitating comprehensive data analysis and the integration of new research findings into clinical practice. Applications extend beyond patient management to supporting clinical trials, protocol development, and collaboration among multidisciplinary teams. The end-use scope mainly encompasses hospitals, cancer research centers, and specialty clinics involved in cancer treatment. Market growth is heavily influenced by technological advancements, rising cancer prevalence, and the increasing adoption of electronic health records (EHRs). Opportunities arise from the integration of artificial intelligence (AI) and machine learning (ML) to enhance predictive analytics and personalized medicine capabilities. Businesses should capitalize on these technologies to offer innovative solutions like real-time analytics and decision support. Challenges facing the market include high implementation costs, stringent regulatory environments, and data security concerns that may hinder the adoption of these systems. Moreover, the integration of legacy systems with modern OIS remains a significant technical obstacle. Innovations should focus on improving interoperability, enhancing cybersecurity measures, and developing cost-effective solutions to broaden access. The oncology information systems market is dynamic, driven by continuous innovations in IT and a push towards value-based cancer care approaches, but requires stakeholders to be agile in addressing the evolving challenges. Research and development should thus aim at smarter, more adaptive systems that further reduce the administrative burden on healthcare providers while simultaneously enhancing patient care quality.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology Information Systems Market

The Oncology Information Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence and prevalence of cancer worldwide
  • Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
  • Favorable government mandates and support for oncology information systems
• Market Restraints
  • Dearth of skilled IT professionals in healthcare industry
• Market Opportunities
  • Integration of advanced technologies with Oncology Information Systems
  • Increasing strategic alliances and investments
• Market Challenges
  • Concerns regarding data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Oncology Information Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology Information Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology Information Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology Information Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology Information Systems Market

A detailed market share analysis in the Oncology Information Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology Information Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology Information Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology Information Systems Market

A strategic analysis of the Oncology Information Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology Information Systems Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Data Systems, Advanced Data Systems Corporation, Allscripts Healthcare Solutions, Inc., Altai AS, CureMD.com, Inc., DOSIsoft SA, Elekta AB, EndoSoft LLC, Epic Systems Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., International Business Machines Corporation, Karkinos Healthcare, Koninklijke Philips N.V., McKesson Corporation, MICA Information Systems, Inc., Oracle Corporation, RaySearch Laboratories, Siemens Healthineers AG, Sify Technologies, UnitedHealth Group Inc., and ViewRay Inc..

Market Segmentation & Coverage

This research report categorizes the Oncology Information Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Solutions, market is studied across Advanced Visualization & Image Analysis Solutions, Brachytherapy Treatment Planning Systems, Chemotherapy Information System, Clinical Decision Support Systems, Clinical Integration Solutions, Laboratory Information Systems, Oncology Electronic Medical Record (EHR), Patient Information Systems, Picture archiving & communication System (PACS) & VNA, Population Health Management, Radiation Dose Management Solutions, Radiology Information systems, Radiotherapy Treatment Planning Systems, Treatment Management Systems & Medical Image Analysis Systems, and Treatment Planning Systems.
• Based on Service, market is studied across Consulting/Optimization Services, Implementation Services, and Post-Sale & Maintenance Services.
• Based on Application, market is studied across Medical Oncology, Radiation Oncology, and Surgical Oncology.
• Based on End User, market is studied across Ablation Care Centers & Cancer Care Centers, Government Institutions, Hospitals & Diagnostic Imaging Centers, and Research Facilities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence and prevalence of cancer worldwide
    • 5.1.1.2. Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
    • 5.1.1.3. Favorable government mandates and support for oncology information systems
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of skilled IT professionals in healthcare industry
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of advanced technologies with Oncology Information Systems
    • 5.1.3.2. Increasing strategic alliances and investments
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding data privacy and security
• 5.2. Market Segmentation Analysis
  • 5.2.1. Solutions: Burgeoning usage of chemotherapy information systems to reduce medication errors
  • 5.2.2. Application: Evolving usage of oncology information systems for surgical oncology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Oncology Information Systems Market, by Solutions

• 6.1. Introduction
• 6.2. Advanced Visualization & Image Analysis Solutions
• 6.3. Brachytherapy Treatment Planning Systems
• 6.4. Chemotherapy Information System
• 6.5. Clinical Decision Support Systems
• 6.6. Clinical Integration Solutions
• 6.7. Laboratory Information Systems
• 6.8. Oncology Electronic Medical Record (EHR)
• 6.9. Patient Information Systems
• 6.10. Picture archiving & communication System (PACS) & VNA
• 6.11. Population Health Management
• 6.12. Radiation Dose Management Solutions
• 6.13. Radiology Information systems
• 6.14. Radiotherapy Treatment Planning Systems
• 6.15. Treatment Management Systems & Medical Image Analysis Systems
• 6.16. Treatment Planning Systems

7. Oncology Information Systems Market, by Service

• 7.1. Introduction
• 7.2. Consulting/Optimization Services
• 7.3. Implementation Services
• 7.4. Post-Sale & Maintenance Services

8. Oncology Information Systems Market, by Application

• 8.1. Introduction
• 8.2. Medical Oncology
• 8.3. Radiation Oncology
• 8.4. Surgical Oncology

9. Oncology Information Systems Market, by End User

• 9.1. Introduction
• 9.2. Ablation Care Centers & Cancer Care Centers
• 9.3. Government Institutions
• 9.4. Hospitals & Diagnostic Imaging Centers
• 9.5. Research Facilities

10. Americas Oncology Information Systems Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Oncology Information Systems Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Oncology Information Systems Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Apollo Cancer Centres launches India's 1st AI-Precision Oncology Centre
  • 13.3.2. GBIN Launches eNautilus Project to Add New Oracle Health EHR Capabilities to Better Support Patient Care
  • 13.3.3. Nova Scotia Health Launches First-In-Canada Technology that Brings Together Oncology Information In Real-Time
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Incorporated
• 2. Advanced Data Systems
• 3. Advanced Data Systems Corporation
• 4. Allscripts Healthcare Solutions, Inc.
• 5. Altai AS
• 6. CureMD.com, Inc.
• 7. DOSIsoft SA
• 8. Elekta AB
• 9. EndoSoft LLC
• 10. Epic Systems Corporation
• 11. F. Hoffmann-La Roche Ltd
• 12. GE HealthCare Technologies Inc.
• 13. International Business Machines Corporation
• 14. Karkinos Healthcare
• 15. Koninklijke Philips N.V.
• 16. McKesson Corporation
• 17. MICA Information Systems, Inc.
• 18. Oracle Corporation
• 19. RaySearch Laboratories
• 20. Siemens Healthineers AG
• 21. Sify Technologies
• 22. UnitedHealth Group Inc.
• 23. ViewRay Inc.